Zemaira 1 mg Injection
RxNorm 991722 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Zemaira 1 mg Injection (RxCUI 991722). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ CSL Behring LLC 3
→ Fisher Clinical Services Inc. 3

CSL Behring LLC

NDC Product
Plasma Derivative

Zemaira
NDC 0053-7201

Generic Name
Alpha-1-proteinase Inhibitor Human
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Zemaira
NDC 0053-7202

Generic Name
.alpha.1-proteinase Inhibitor Human
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Zemaira
NDC 0053-7203

Generic Name
.alpha.1-proteinase Inhibitor Human
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing

Fisher Clinical Services Inc.

NDC Product
Plasma Derivative

Zemaira
NDC 57516-101

Generic Name
Alpha-1-proteinase Inhibitor Human Kit
Dosage Form
Kit
Route
Intravenous
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Zemaira
NDC 57516-110

Generic Name
Alpha-1-proteinase Inhibitor Human Kit
Dosage Form
Kit
Route
Intravenous
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Zemaira
NDC 57516-113

Generic Name
Alpha-1-proteinase Inhibitor Human Kit
Dosage Form
Kit
Route
Intravenous
Marketing
BLA
Active Listing